Literature DB >> 16983142

Symptomatic myopathy due to red yeast rice.

Paul S Mueller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16983142     DOI： 10.7326/0003-4819-145-6-200609190-00021

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

Review 1.  The role of red yeast rice for the physician.

Authors:  Ram Y Gordon; David J Becker
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

2.  Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system.

Authors:  Gabriela Mazzanti; Paola Angela Moro; Emanuel Raschi; Roberto Da Cas; Francesca Menniti-Ippolito
Journal:  Br J Clin Pharmacol       Date:  2017-01-19       Impact factor: 4.335

3.  An alternative treatment of hyperlipidemia with red yeast rice: a case report.

Authors:  James S Lin
Journal:  J Med Case Rep       Date:  2010-01-08

4.  Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia.

Authors:  Matthew Klimek; Shan Wang; Adeleye Ogunkanmi
Journal:  P T       Date:  2009-06

5.  Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.

Authors:  Emanuel Raschi; Anna Girardi; Elisabetta Poluzzi; Emanuele Forcesi; Francesca Menniti-Ippolito; Gabriela Mazzanti; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

6.  NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements.

Authors:  Dirk W Lachenmeier; Yulia B Monakhova; Thomas Kuballa; Sigrid Löbell-Behrends; Sibylle Maixner; Matthias Kohl-Himmelseher; Asja Waldner; Christian Steffen
Journal:  Chin Med       Date:  2012-03-22       Impact factor: 5.455

7.  Decreased Risk of Stroke in People Using Red Yeast Rice Prescriptions (LipoCol Forte®): a Total Population-Based Retrospective Cohort Study.

Authors:  Chuen-Chau Chang; Mao-Feng Sun; Yi-Chun Chou; Chun-Chieh Yeh; Chaur-Jong Hu; Yih-Giun Cherng; Ta-Liang Chen; Chien-Chang Liao
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-23       Impact factor: 2.650

8.  Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial.

Authors:  Veronique Verhoeven; Anastasia Van der Auwera; Luc Van Gaal; Roy Remmen; Sandra Apers; Michel Stalpaert; Johan Wens; Nina Hermans
Journal:  BMC Complement Altern Med       Date:  2015-03-10       Impact factor: 3.659

9.  Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin.

Authors:  Chia-Hao Chen; Yow-Shieng Uang; Shang-Ta Wang; Jyh-Chin Yang; Chun-Jung Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-14       Impact factor: 2.629

10.  Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.

Authors:  Veronique Verhoeven; Maja Lopez Hartmann; Roy Remmen; Johan Wens; Sandra Apers; Paul Van Royen
Journal:  BMC Complement Altern Med       Date:  2013-07-18       Impact factor: 3.659
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.